CIK 0000818033 · Accelerated filer
HERON THERAPEUTICS, INC. /DE/
Sign in to watch- Ticker
- HRTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 942875566
- Phone
- 8582514400
- Business address
- 4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA, 92121
- Former names
- AP PHARMA INC /DE/, ADVANCED POLYMER SYSTEMS INC /DE/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-07-31 | Duarte Ira EVP, Chief Financial Officer | Option exercise | +11,695 | 164,218 | ||
| 2025-07-31 | Duarte Ira EVP, Chief Financial Officer | Option exercise · Restricted Stock Units | −11,695 | 163,721 | ||
| 2025-07-31 | Collard Craig A Chief Executive Officer | Option exercise | +34,789 | 474,538 | ||
| 2025-07-31 | Collard Craig A Chief Executive Officer | Option exercise · Restricted Stock Units | −34,789 | 487,042 | ||
| 2025-07-19 | Forbes William P EVP, Chief Development Officer | Option exercise | +3,874 | 138,940 | ||
| 2025-07-19 | Forbes William P EVP, Chief Development Officer | Option exercise · Restricted Stock Units | −3,874 | 38,743 | ||
| 2025-07-19 | Duarte Ira EVP, Chief Financial Officer | Option exercise | +3,874 | 152,523 | ||
| 2025-07-19 | Duarte Ira EVP, Chief Financial Officer | Option exercise · Restricted Stock Units | −3,874 | 38,743 | ||
| 2025-07-19 | Collard Craig A Chief Executive Officer | Option exercise | +13,797 | 439,749 | ||
| 2025-07-19 | Collard Craig A Chief Executive Officer | Option exercise · Restricted Stock Units | −13,797 | 137,969 | ||
| 2025-06-16 | Duarte Ira EVP, Chief Financial Officer | Option exercise | +12,500 | 148,649 | ||
| 2025-06-16 | Duarte Ira EVP, Chief Financial Officer | Option exercise · Restricted Stock Units | +12,500 | 25,000 | ||
| 2025-06-06 | Forbes William P EVP, Chief Development Officer | Option exercise | +12,500 | 135,066 | ||
| 2025-06-06 | Forbes William P EVP, Chief Development Officer | Option exercise · Restricted Stock Units | −12,500 | 25,000 | ||
| 2025-05-06 | Hensley Mark Earl Chief Operating Officer | Grant or award · Restricted Stock Units | +500,000 | 500,000 | ||
| 2025-04-30 | Forbes William P EVP, Chief Development Officer | Option exercise | +11,694 | 122,566 | ||
| 2025-04-30 | Forbes William P EVP, Chief Development Officer | Option exercise · Restricted Stock Units | −11,694 | 175,416 | ||
| 2025-04-30 | Duarte Ira EVP, Chief Financial Officer | Option exercise | +11,694 | 136,149 | ||
| 2025-04-30 | Duarte Ira EVP, Chief Financial Officer | Option exercise · Restricted Stock Units | +11,694 | 175,416 | ||
| 2025-04-30 | Collard Craig A Chief Executive Officer | Option exercise | +34,789 | 425,952 |
Page 8 of 28 · 557 trades